Pregled nacrta

This document specifies requirements and test methods for operating lights used in the dental office and intended for illuminating the oral cavity of patients. It also contains specifications on the instructions for use, marking and packaging.
This document applies to operating lights, irrespective of the technology of the light source.
This document excludes auxiliary light sources, for example, from dental handpieces and dental headlamps and also operating lights which are specifically designed for use in oral surgery.

This document deals with whole body vibration as a significant hazard. It also specifies the methods for determining the vibration emission transmitted to the whole body of drivers standing and/or seated on freely moveable GSE, when driving for purposes of type evaluation, declaration and methods of verifying vibration emission.
The test results are not applicable to the determination of whole body vibration exposure of persons.

ISO/IEC 17024:2012 contains principles and requirements for a body certifying persons against specific requirements, and includes the development and maintenance of a certification scheme for persons.

This document specifies a process for a medical laboratory to identify and manage the risks to patients, laboratory workers and service providers that are associated with medical laboratory examinations. The process includes identifying, estimating, evaluating, controlling and monitoring the risks.
The requirements of this document are applicable to all aspects of the examinations and services of a medical laboratory, including the pre-examination and post-examination aspects, examinations, accurate transmission of test results into the electronic medical record and other technical and management processes described in ISO 15189.
This document does not specify acceptable levels of risk.
This document does not apply to risks from post-examination clinical decisions made by healthcare providers.
This document does not apply to the management of risks affecting medical laboratory enterprises that are addressed by ISO 31000, such as business, economic, legal, and regulatory risks.

ISO/IEC 17024:2012 contains principles and requirements for a body certifying persons against specific requirements, and includes the development and maintenance of a certification scheme for persons.

This Recommendation | International Standard establishes controls, purpose, and guidance for implementing controls, to meet the requirements identified by a risk and impact assessment related to the protection of personally identifiable information (PII).
In particular, this Recommendation | International Standard specifies guidance based on ISO/IEC 27002, taking into consideration the controls for processing PII that may be applicable within the context of an organization's information security risk environment(s).
This Recommendation | International Standard is applicable to all types and sizes of organizations acting as PII controllers (as defined in ISO/IEC 29100), including public and private companies, government entities and not-for-profit organizations that process PII, in particular, organizations that do not establish or operate a privacy information management system.

This document specifies a process for a medical laboratory to identify and manage the risks to patients, laboratory workers and service providers that are associated with medical laboratory examinations. The process includes identifying, estimating, evaluating, controlling and monitoring the risks.
The requirements of this document are applicable to all aspects of the examinations and services of a medical laboratory, including the pre-examination and post-examination aspects, examinations, accurate transmission of test results into the electronic medical record and other technical and management processes described in ISO 15189.
This document does not specify acceptable levels of risk.
This document does not apply to risks from post-examination clinical decisions made by healthcare providers.
This document does not apply to the management of risks affecting medical laboratory enterprises that are addressed by ISO 31000, such as business, economic, legal, and regulatory risks.

This document specifies the technical requirements of rectangular connectors with sealed and non-sealed rear, plastic housing, locking device, for operating temperatures from -55 °C to 175 °C.

This document specifies the requirements relating to:
Steel GX5CrNiCuNb16-4 (1.4525)
Homogenized
Solution treated and precipitation hardened
Investment casting
De ≤ 50 mm
Rm ≥ 900 MPa
for aerospace applications.

This document defines basic terms, symbols, and units of measurement for the field of laser technology in order to unify the terminology and to arrive at clear definitions and reproducible tests of beam parameters and laser-oriented product properties.
NOTE The laser hierarchical vocabulary laid down in this document differs from that given in IEC 60825?1. ISO and IEC have discussed this difference and agree that it reflects the different purposes for which the two standards serve. For more details, see informative Annex A.

This document specifies the requirements and test procedures for 360° visibility of self-propelled industrial rider-controlled pallet-stacking trucks in accordance with ISO 5053-1 (herein after referred to as trucks), without a load and it is intended to be used in conjunction with EN 16842-1.
This document also applies to pedestrian controlled trucks with foldable platform when used in ride-on mode.
Pedestrian-controlled and pedestrian-propelled trucks are not covered by this document.
Where specific requirements in this part are modified from the general requirements in EN 16842-1, the requirements of this part are truck specific and intended to be used for self-propelled industrial stand-on pallet-stacking trucks.
This part of EN 16842 deals with all significant hazards, hazardous situations or hazardous events relevant to the visibility of the operator for applicable machines when used as intended and under conditions of misuse which are reasonably foreseeable by the manufacturer.

This European Standard specifies requirements for chemical and physical properties, and minimum performance requirements of medium expansion foams suitable for surface application to water-immiscible liquids. Requirements are also given for marking.
WARNING - Any type approval according to this standard is invalidated by any change in composition of the approved product.
Some concentrates conforming to this part of EN 1568 can also conform to other parts and therefore can also be suitable for application as low and/or high expansion foams.

This European Standard specifies requirements for chemical and physical properties, and minimum performance requirements of high expansion foams suitable for surface application to water-immiscible liquids. Requirements are also given for marking.
WARNING - Any type approval according to this standard is invalidated by any change in composition of the approved product.
Some concentrates conforming to this part of EN 1568 can also conform to other parts and therefore can also be suitable for application as low and/or medium expansion foams.

This European Standard specifies requirements for chemical and physical properties, and minimum performance requirements of low expansion foams suitable for surface application to water-immiscible liquids. Requirements are also given for marking.
WARNING - Any type approval according to this standard is invalidated by any change in composition of the approved product.
Some concentrates conforming to this part of EN 1568 can also conform to other parts and therefore can also be suitable for application as medium and/or high expansion foams, and for application at low expansion to water-miscible liquids.

Identical scope from ISO 22359:2024

This document specifies the control and approval of in vitro diagnostic reagents used in animal health for the detection, and/or absolute quantification of pathogen-specific nucleic acid (DNA or RNA) by PCR (e.g. endpoint PCR, real-time PCR, reverse transcription-PCR).
This document is applicable to diagnostic reagents as a priority for infectious diseases (due to bacteria, viruses, fungi, or parasites, including genetic markers associated with pathogenicity, such as antimicrobial resistance or toxin production) and associated animal species for which harmonization of practices in this area is needed, i.e. those for which the national, regional or international regulatory framework provides for the control of trade in animals and/or animal products and/or the definition of a health status (absence of infection) of areas, establishments or individuals. Anyhow, all reagents designated by the competent authorities fall under the scope of this document. Nevertheless, the authorities or any other animal health stakeholder can choose to derogate in specific and very limited situations such as emerging, exotic or rare diseases.
This document is not applicable to all existing diagnostic reagents, in particular those for which certain parameters described in this document cannot be validly evaluated in accordance with international requirements, due, e.g. to the absence of a specific reference standard and/or accessible and duly validated reference materials.
The PCR diagnosis usually involves the use of a nucleic acid extraction and/or purification reagent, and a PCR reagent. The PCR method (when applicable) involves the successive use of these distinct reagents. PCR reagent control can be performed if the applicant provides evidence of the validity of the PCR reagent for use in the animal health diagnostic analysis, by proving its diagnostic performances with nucleic acid extracts obtained from the different matrices described in the instruction for use. The control of a complete PCR method by the applicant and the control organization is performed only if the PCR reagent cannot be dissociated from an nucleic acid extraction and/or purification systems. This document does not cover the control of the nucleic acid extraction and/or purification reagents, only.
This document does not cover the step in which the user verifies a reagent (analysis method adoption).
NOTE   Prion diseases are not included in the scope of this third part of the EN 18000 series. Unlike other infectious diseases, prion diseases are not diagnosed using PCR assays because prions lack a nucleic acid component and consist solely of an abnormally folded conformer of the normal host protein.